Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

MBio Diagnostics receives NIH grant to continue development of POC HIV diagnostic device

July 23, 2013

Janssen and Pepscan patent novel polypeptide HIV fusion inhibitors

July 18, 2013

Boehringer Ingelheim divulges novel reverse transcriptase inhibitors

July 12, 2013

Janssen announces approval of a high-dose HIV therapeutic

July 11, 2013

Calimmune commences phase I/II trial of gene medicine for HIV

July 10, 2013

Gilead Sciences presents further clinical data on Stribild

July 9, 2013

Coadministration of long-acting GSK-744 and rilpivirine found feasible

July 8, 2013

Results from phase III trials of dolutegravir presented

July 5, 2013

In vitro and in vivo anti-HIV activity of a novel HIV-1 splicing inhibitor

July 4, 2013

Janssen presents bioequivalence results for darunavir/cobicistat fixed-drug combination

July 3, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...